Intravitreous Anti–VEGF vs Sham Treatment for Prevention of Vision-Threatening Complications of Diabetic Retinopathy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
JAMA Ophthalmology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Effect of Intravitreous Anti-Vascular Endothelial Growth Factor vs Sham Treatment for Prevention of Vision-Threatening Complications of Diabetic Retinopathy: The Protocol W Randomized Clinical Trial
JAMA Ophthalmol 2021 Mar 30;[EPub Ahead of Print], RK Maturi, AR Glassman, K Josic, AN Antoszyk, BA Blodi, LM Jampol, DM Marcus, DF Martin, M Melia, H Salehi-Had, CR Stockdale, OS Punjabi, JK SunFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.